516,444. Acetylene-cyclopentanophenanthrene compounds. SOC. OF CHEMICAL INDUSTRY IN BASLE. June 27, 1938, Nos. 18992, 18993, 18994 and 18995. Convention dates, June 26, 1937, Aug. 7, 1937, Jan. 18, 1938, and May 12, 1938. [Class 2 (iii)] Acetylene derivatives of the cyclopentanopolyhydrophenanthrene series are-prepared by the reaction of a ketohe of this series with a metal salt of an acetylene or a monosubstituted acetylene in a homogenous liquid phase, and the addition product so produced is hydrolysed or treated with an alkylating or an acylating agent. Parent materials are saturated or unsaturated ketones of the above series, and those specified include the androstanolones such as androsterones or dihydro-testosterones, androstenolones such as dehydroandrosterones, androstane-diones, androstene-diones, oestrone hexahydro-oestrone, equiline, pregnanolones, pregnenolones, pregnane-diones, and pregnenediones. Metal salts of acetylenes or substituted acetylenes includes compounds in which the hydrogen atom of a -C#CH group is replaced by an equivalent of a metal such as sodium potassium, lithium; or copper salts. Substituted acetylenes mentioned include phenylacetylene, acetylene carboxylic acids such as acetylene acetic acid, acetylene propionic acid, acetylene butyric acid, acetylene malonic acid and derivatives of these, such as salts, esters or amides. The reaction may be conducted in the presence of liquid ammonia, an amine such as aniline, an alkylated aniline, pyridine, piperidine, or quinoline, or in the presence of a tertiary alcohol such as tertiary butyl or amyl alcohol. An additional solvent such as an ether or an aromatic hydrocarbon may also be present. Previously prepared solutions of the metal acetylide may be used such as are formed by conducting acetylene into a solution of an alkali metal or alkali amide in anhydrous ammonia, or by introducing an alkali metal or an alkali amide into a solution of acetylene in anhydrous ammonia or in a tertiary alcohol. The addition product which possesses the general formula where R is hydrogen or a substituted or non- substituted hydrocarbon or carboxyl group and Me is a metal hydrolysed by water or acid to the corresponding tertiary alcohol or is reacted with an alkylating agent to produce an ether or with an acylating agent to produce an ester. Alkylating agents mentioned include alkyl or alkylene halides such as methyl iodide, propyl iodide, alkyl bromide, benzyl bromide, chloromethyl ether, triarylmethyl chlorides, and the reactive esters of alcohols such as dialkyl sulphates. Acylating agents mentioned include acid halides such as acetyl-, propionyl-., and benzoyl-chloride, toluene sulpho-chloride, chlorocarbonic acid esters and acid anhydrides. In examples (1) potassium is dissolved in liquid ammonia cooled with acetone and carbonic acid snow. Acetylene is led into the blue solution until it is decolourized, and a benzene solution of trans-dehydroandrosterone is added. Ice is added and the unreacted parent ketone is removed and the residue comprising #<;5>;.<;6>;-17- ethinyl-androstene-diol-3:17 is crystallized. On acetylation with acetic anhydride in pyridine at room temperature the corresponding monoacetate is formed. (2) Trans-androsterone is condensed with acetylene as in example (1) to give 17-ethinyl-androstane-diol-3:17. (3) The #<;5À6>;-17 ethinyl-androstene diol-3:17 prepared in example (1) is acetylated with acetic anhydride in pyridine at raised temperature to form the corresponding diacetate. (4) An ether solution of 1-ethinyl-propionic acid ethyl ester is added to a solution of sodium in liquid ammonia cooled as in example (1). An ether-benzene solution of trans-dehydroandrosterone is now added and the product worked up as in example (1) to give a condensation product of the formula The 1-ethinyl-propionic acid ethyl ester may be made by passing acetylene into a solution of sodium in liquid ammonia, adding benzene, evaporating the ammonia, and treating the product with alphabromopropionic acid ethyl ester. (5) A solution of potassium in tertiary butyl alcohol is added to a solution of acetylene in dry ether at -20C., and an ether solution of trans-dehydroandrosterone added. The product is then worked up as before to give #<;5.6>;-17-ethinyl-androstene-diol-3:17. (6) Transandrosterone is reacted with acetylene as in example (5) to give 17-ethinyl-androstane-diol- 3:17. (7) Acetylene is passed into a solution of potassium in liquid ammonia and a solution of oestrone in dioxane added. The product is worked up to give 17-ethinyl-oestradiol-3:17. The corresponding diacetate is prepared by heating with pyridine and acetic anhydride. Specification 468,123 is referred to. The Specification as open to inspection under Sect. 91 includes also as parent materials aetio-cholenyl-17-aldehydes, compounds of the suprannal cortical hormone series, cholestanone, and cholestenone. The metal salts which may be used include also rubidium, caesium and silver salts of acetylene or mono-substituted acetylenes. Moreover the use of previously prepared suspensions of the metal acetylide may be used. 'The derivatives of the compounds formed by the process of the present invention includes also glucosides. This subject-matter does not appear in the Specification as accepted.;5.6>;5À6>;6>;5>
516,444.
乙炔-环戊
苯并
蒽化合物。巴塞尔
化学工业协会。1938年6月27日,编号18992、18993、18994和18995。公约日期,1937年6月26日、1937年8月7日、1938年1月18日和1938年5月12日。[2类(iii)] 环戊
苯并
蒽系列的
乙炔衍
生物是通过该系列的
酮与
乙炔或单取代
乙炔的
金属盐在均相液相中反应制备的,所产生的加成产物经
水解或与烷基化或酰化剂处理。母体材料是上述系列的饱和或不饱和
酮,具体包括雄甾
酮酮类似物,如雄甾
酮或二
氢睾酮,雄甾
酮类似物,如去
氢雄甾
酮,雄烷二
酮,
雄烯二酮,
雌酮,六
氢雌酮,伊奎林,
孕酮酮,孕醇
酮,孕烷二
酮和
孕烯二酮。
乙炔或取代
乙炔的
金属盐包括其中-C#CH基团的
氢原子被
钠、
钾、
锂等
金属的当量所取代的化合物;或
铜盐。提到的取代
乙炔包括
苯乙炔,
乙炔羧酸,如
乙炔乙酸,
乙炔丙酸,
乙炔丁酸,
乙炔丙二酸和这些的衍
生物,如盐、
酯或
酰胺。反应可以在液
氨、
苯胺、烷基化
苯胺、
吡啶、
哌啶或
喹啉等存在的情况下进行,或者在
三级醇,如叔丁基或
戊醇存在的情况下进行。也可以存在额外的溶剂,如醚或
芳香烃。事先制备的
金属
乙炔化物的溶液可以使用,例如通过将
乙炔导入无
水氨溶液中的碱
金属或碱
金属
酰胺中形成的溶液,或者通过将碱
金属或碱
金属
酰胺引入无
水氨或
三级醇中的
乙炔溶液中形成的溶液。具有一般公式的加成产物,其中R是
氢或取代或非取代的
碳氢化合物或羧基,Me是被
水或酸
水解为相应的
三级醇或与烷基化剂反应生成醚或与酰化剂反应生成
酯的
金属。提到的烷基化剂包括
甲基碘化物、丙基
碘化物、烷基
溴化物、苄
溴化物、
氯甲醚、三芳基
甲基氯化物和醇的反应
酯,如二烷基
硫酸酯。提到的酰化剂包括酸卤,如
乙酰氯、
丙酰氯和
苯甲酰氯,甲
苯磺酰氯,
氯碳酸酯和酸酐。在示例中(1)中,
钾在液
氨中与
丙酮和
二氧化碳雪冷却混合。将
乙炔导入蓝色溶液中,直到
脱色,然后加入反式去
氢雄甾
酮的
苯溶液。加入冰,去除未反应的母
酮,残留物包括#<;5>;.<;6>;-17-
乙炔基-
雄烯二醇-3:17结晶。在室温下在
吡啶中用
乙酸酐乙酸化后,形成相应的单
乙酸酯。(2)反式雄甾
酮与
乙炔如示例(1)中凝结,得到17-
乙炔基-
雄烷二醇-3:17。(3)在示例(1)中制备的#<;5À6>;-17
乙炔基-
雄烯二醇-3:17在
吡啶中升温用
乙酸酐乙酸化,形成相应的二
乙酸酯。(4)1-
乙炔基-
丙酸乙酯的醚溶液加入到液
氨中
钠的溶液中,如示例(1)中冷却。现在加入反式去
氢雄甾
酮的醚-
苯溶液,并像示例(1)中那样处理产物,得到公式的缩合产物。1-
乙炔基-
丙酸乙酯可以通过将
乙炔通入液
氨中的
钠溶液中,加入
苯,蒸发
氨,并用α-
溴丙酸乙酯处理产物制备。(5)在-20°C下,将
钾在三
丁醇中的溶液加入到干醚中的
乙炔溶液中,然后加入反式去
氢雄甾
酮的醚溶液。然后像以前一样处理产物,得到#<;5.6>;-17-
乙炔基-
雄烯二醇-3:17。(6)反式雄甾
酮与
乙炔反应,如示例(5)中,得到17-
乙炔基-
雄烷二醇-3:17。(7)将
乙炔导入液
氨中的
钾溶液中,然后加入二
氧杂
环己酮的二
氧六
环己酮溶液。处理产物,得到17-
乙炔基-
雌二醇-3:17。通过与
吡啶和
乙酸酐加热制备相应的二
乙酸酯。参考规范468,123。根据第91条开放检查的规范还包括作为母体材料的aetio-胆甾
烯基-17-醛、超
肾上腺皮质激素系列化合物、
胆甾酮和胆甾
烯酮。可以使用的
金属盐还包括
铷、
铯和
乙炔或单取代
乙炔的
银盐。此外,还可以使用事先制备的
金属
乙炔化物的悬浮液。‘本发明过程形成的化合物的衍
生物还包括
葡萄糖苷。这一主题在已接受的规范中没有出现。;5.6>;5À6>;6>;5>